Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Nicholson

Showing results (281-290 of 357) with videos related to

Pageof 36
Sort By:
Human Molecular Genetics|September 22, 2005
Dilated cardiomyopathy in the nmd mouse: transgenic rescue and QTLs that improve cardiac function and survivalTerry P Maddatu, Sean M Garvey, David G Schroeder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1996
Cyclin D1 and estrogen receptor messenger RNA levels are positively correlated in primary breast cancerR Hui, A L Cornish, R A McClelland, et al.
British Journal of Cancer|July 4, 1998
Oestrogen-regulated genes in breast cancer: association of pLIV1 with response to endocrine therapyR A McClelland, D L Manning, J M Gee, et al.
Breast Cancer Research and Treatment|November 2, 2005
Bidirectional cross talk between ERalpha and EGFR signalling pathways regulates tamoxifen-resistant growthD J Britton, I R Hutcheson, J M Knowlden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 1999
Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancerF S Kenny, R Hui, E A Musgrove, et al.
Endocrine-Related Cancer|January 30, 2007
Inductive mechanisms limiting response to anti-epidermal growth factor receptor therapyIain R Hutcheson, Janice M Knowlden, Helen E Jones, et al.
The Journal of Clinical Endocrinology and Metabolism|November 14, 1997
Coexpression and cross-regulation of the prolactin receptor and sex steroid hormone receptors in breast cancerC J Ormandy, R E Hall, D L Manning, et al.
International Journal of Cancer|April 6, 2001
Effect of dietary GLA+/-tamoxifen on the growth, ER expression and fatty acid profile of ER positive human breast cancer xenograftsF S Kenny, J M Gee, R I Nicholson, et al.
Journal of Steroid Biochemistry|January 1, 1984
Therapeutic significance and the mechanism of action of the LH-RH agonist ICI 118630 in breast and prostate cancerR I Nicholson, K J Walker, A Turkes, et al.
The Prostate|May 7, 2002
Multiple responses to EGF receptor activation and their abrogation by a specific EGF receptor tyrosine kinase inhibitorMaureen E Harper, Lindy Goddard, Eve Glynne-Jones, et al.
Pageof 36

Showing results (281-290 of 357) with videos related to

Sort By:
Pageof 36
Human Molecular Genetics|September 22, 2005
Dilated cardiomyopathy in the nmd mouse: transgenic rescue and QTLs that improve cardiac function and survivalTerry P Maddatu, Sean M Garvey, David G Schroeder, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 1, 1996
Cyclin D1 and estrogen receptor messenger RNA levels are positively correlated in primary breast cancerR Hui, A L Cornish, R A McClelland, et al.
British Journal of Cancer|July 4, 1998
Oestrogen-regulated genes in breast cancer: association of pLIV1 with response to endocrine therapyR A McClelland, D L Manning, J M Gee, et al.
Breast Cancer Research and Treatment|November 2, 2005
Bidirectional cross talk between ERalpha and EGFR signalling pathways regulates tamoxifen-resistant growthD J Britton, I R Hutcheson, J M Knowlden, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 1999
Overexpression of cyclin D1 messenger RNA predicts for poor prognosis in estrogen receptor-positive breast cancerF S Kenny, R Hui, E A Musgrove, et al.
Endocrine-Related Cancer|January 30, 2007
Inductive mechanisms limiting response to anti-epidermal growth factor receptor therapyIain R Hutcheson, Janice M Knowlden, Helen E Jones, et al.
The Journal of Clinical Endocrinology and Metabolism|November 14, 1997
Coexpression and cross-regulation of the prolactin receptor and sex steroid hormone receptors in breast cancerC J Ormandy, R E Hall, D L Manning, et al.
International Journal of Cancer|April 6, 2001
Effect of dietary GLA+/-tamoxifen on the growth, ER expression and fatty acid profile of ER positive human breast cancer xenograftsF S Kenny, J M Gee, R I Nicholson, et al.
Journal of Steroid Biochemistry|January 1, 1984
Therapeutic significance and the mechanism of action of the LH-RH agonist ICI 118630 in breast and prostate cancerR I Nicholson, K J Walker, A Turkes, et al.
The Prostate|May 7, 2002
Multiple responses to EGF receptor activation and their abrogation by a specific EGF receptor tyrosine kinase inhibitorMaureen E Harper, Lindy Goddard, Eve Glynne-Jones, et al.
Pageof 36